NCT06900699Not yet recruiting
Clinicopathological Features , Outcomes and Prognostic Factors of High Risk Patients of Gestational Trophoblastic Neoplasia
Clinico-pathological Features and Outcomes of High Risk Gestational Trophoblastic Neoplasia Patients: an Observational Cross-sectional Study
Source: ClinicalTrials.gov · Last updated 28 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Aim of the Study This study aims to investigate the clinical and pathological features, treatment outcomes, and prognostic factors in high-risk patients with Gestational Trophoblastic Neoplasia (GTN). Objectives: * Identify common clinical and pathological features of high-risk GTN patients. * Required surgical treatment as primary or subsequent line. * Evaluate how well different treatments work and their side effects. * Find factors that can help predict patient outcomes. * Compare survival rates and relapse risks among patients.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 42 (estimated)
- First submitted
- 16 Mar 2025
- Start date
- 1 Apr 2025
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- Assiut University
- NCT number
- NCT06900699
What you commit to
- Study type: Observational
- Planned participants: 42
- From 1 Apr 2025 to the primary completion date, 30 Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Previous Malignancy - Patients with a history of other malignancies that may confound outcomes.
- Non-GTN Gestational Trophoblastic Disease (GTD) - Patients with benign conditions such as complete or partial hydatidiform mole without progression to GTN.
- Pregnant at Diagnosis - Patients diagnosed with GTN during an ongoing pregnancy.
- Severe Comorbidities - Patients with significant non-GTN-related illnesses that could affect survival outcomes (e.g., severe heart, liver, or renal disease)
Who the study is looking for
- • Patients diagnosed as high risk patient according to WHO classification\[10\]
- Adequate clinical data available, including demographic, pathological, and treatment-related details.
- Patients treated at Assuit university women's health hospital within a specified period (e.g., observational study covering period from Jan 2020 till dec 2025).
Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.